Prevalence: 37 million Americans with diabetes; 96 million with prediabetes (38% of US adults)
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
The most evidence-backed supplement for blood sugar is berberine (1000-1500mg daily, shown to reduce fasting glucose and HbA1c comparably to metformin in some trials). Magnesium (300-400mg) also supports insulin sensitivity, especially in those with deficiency.
Over 37 million Americans have diabetes and 96 million have prediabetes, representing 38% of US adults. Blood sugar dysregulation is a key driver of metabolic syndrome, cardiovascular disease, and accelerated aging. Several supplements have demonstrated clinically meaningful effects on fasting glucose and HbA1c in well-designed trials.
Several head-to-head clinical trials have found berberine comparable to metformin for reducing fasting blood glucose and HbA1c. A landmark trial published in Metabolism showed berberine lowered HbA1c by 0.71% and fasting glucose by 25 mg/dL—similar to metformin in the same study. However, berberine is a supplement, not a pharmaceutical, and should not replace prescribed diabetes medication without physician guidance. It may be most appropriate for prediabetes or as a complementary approach alongside standard care.
Yes, magnesium plays a critical role in insulin signaling and glucose metabolism. An estimated 25-38% of people with type 2 diabetes have low magnesium levels, which worsens insulin resistance. Meta-analyses show that magnesium supplementation at 300-400mg daily reduces fasting glucose by approximately 4.64 mg/dL, with significantly greater effects in individuals who are magnesium-deficient. Magnesium glycinate or citrate forms are preferred for bioavailability.